SOLITAIRE FR With the Intention For Thrombectomy as PRIMary Endovascular Treatment for Acute Ischemic Stroke | Clinical Trial - SWIFT PRIME


The goal of the trial was to compare the role of endovascular therapy as an adjunct to intravenous (IV) thrombolysis in patients presenting with acute ischemic stroke within 6 hours of symptom onset, compared with IV thrombolysis alone.

Contribution to the Literature: The SWIFT PRIME study on eligible patients presenting with an acute ischemic stroke suggests that endovascular therapy is superior in improving perfusion, neurological, and functional outcomes compared with IV thrombolysi...